Batu Biologics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Batu Biologics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10940
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Batu Biologics Inc (Batu Biologics) is an immuno-oncology company. The company offers development and commercialization of novel therapies that target the Achilles Heel of cancer: the tumor blood vessels. Its lead product ValloVax is a cellular anti-angiogenic cancer vaccine that is developed to induce an immune response against the tumor endothelium of non small cell lung cancer. Batu Biologics’ pipeline products include Immitam, DendroVax, and ImmXcyte. The company’s products find application in treating of cancers such as lung cancer, glioblastoma, and all other solid tumors. Its in partnership with academic institutions carries research work in the field of cancer immunotherapy. The company operates a research facility located at Janssen Research and Development in California, the US. Batu Biologics is headquartered in San Diego, California, the US.

Batu Biologics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Batu Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Batu Biologics Raises USD1.3 Million in Venture Financing 10
Batu Biologics Raises USD0.1 Million in Venture Financing 11
Batu Biologics Raises USD0.35 Million in Venture Financing 12
Batu Biologics Raises USD1 Million in Seed Financing 13
Batu Biologics Raises USD0.1 Million in Venture Financing 14
Licensing Agreements 15
Batu Biologics Enters into Licensing Agreement with University of California, San Diego 15
Batu Biologics Inc – Key Competitors 16
Batu Biologics Inc – Key Employees 17
Batu Biologics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Mar 24, 2018: Appoints Dr. Francesco Marincola As Clinical Advisory Board Chairman 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Batu Biologics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Batu Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Batu Biologics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Batu Biologics Raises USD1.3 Million in Venture Financing 10
Batu Biologics Raises USD0.1 Million in Venture Financing 11
Batu Biologics Raises USD0.35 Million in Venture Financing 12
Batu Biologics Raises USD1 Million in Seed Financing 13
Batu Biologics Raises USD0.1 Million in Venture Financing 14
Batu Biologics Enters into Licensing Agreement with University of California, San Diego 15
Batu Biologics Inc, Key Competitors 16
Batu Biologics Inc, Key Employees 17
Batu Biologics Inc, Other Locations 18

List of Figures
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Batu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Batu Biologics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ana Holdings Inc:企業の戦略・SWOT・財務情報
    Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Indowind Energy Ltd (INDOWIND):電力:M&Aディール及び事業提携情報
    Summary Indowind Energy Ltd (Indowind Energy) is a renewable energy company that develops and manages wind farms and wind assets, and generates green power for sale to utilities and corporate. The company offers project management, wind asset management, and value addition services. It also provides …
  • NVIDIA Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NVIDIA Corporation Mergers and …
  • Shenzhen Gas Corporation Ltd (601139):企業の財務及び戦略的SWOT分析
    Summary Shenzhen Gas Corporation Ltd (Shenzhen Gas) is an oil and gas company that offers wholesale and retail of liquefied petroleum gas. The company’s services include distribution, resident customer service and industrial services. It provides resident customer services such as 24-hour hotline se …
  • GI Dynamics Inc (GID):企業財務及び戦略的SWOT分析
    Summary GI Dynamics Inc (GI Dynamics) is a medical service provider that develops and commercializes non-surgical treatments for patients. The company’s product includes EndoBarrier therapy. Its product EndoBarrier is an endoscopically delivered device therapy that is designed to mimic the mechanism …
  • Nestle Health Science SA:企業のM&A・提携動向(医療分野)
    Summary Nestle Health Science SA (Nestle Health), a subsidiary of Nestle SA is a health science company that offers nutritional solutions to meet specific dietary needs related to illnesses and special challenges in different stages of life. It manufactures and commercializes new nutritional and med …
  • DEA Deutsche Erdoel AG:石油・ガス:M&Aディール及び事業提携情報
    Summary DEA Deutsche Erdoel AG (DEA), a subsidiary of Letterone Holdings S.A., is an upstream company that explores for and produces oil and natural gas. The company operates onshore and offshore projects in Egyptian Nile delta, Mittelplate Island and Norwegian coast line and other regions. It also …
  • Elecnor SA (ENO):企業の財務・戦略的SWOT分析
    Elecnor SA (ENO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nishio Rent All Co.,Ltd. (9699):企業の財務及び戦略的SWOT分析
    Nishio Rent All Co.,Ltd. (9699) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • PetroQuest Energy, Inc. (PQ)(石油・ガス分野):企業M&A動向
    Summary PetroQuest Energy, Inc. (PetroQuest) is an energy company. The company carries out exploration, production and discovery of oil and natural gas properties. It has exploration and production activities in East Texas, Arkoma Basin, South Louisiana and the shallow waters of the Gulf of Mexico. …
  • Chori Co., Ltd. (8014):企業財務及び戦略的SWOT分析
    Summary Chori Co., Ltd. (Chori), a subsidiary of Toray Industries, Inc. is a chemical company that offers trading of textiles, chemicals and machineries. The company offers products such as synthetic fiber and automotive fabrics, performance fibers, textile goods, chemicals and machineries; and othe …
  • InfuSystem Holdings Inc (INFU):企業の財務・戦略的SWOT分析
    Summary InfuSystem Holdings Inc (InfuSystem) is a provider of infusion pumps and related services. The company provides ambulatory infusion pumps and associated clinical services. Its patient services comprise infucare help hotline, infuease, education, and pain management. InfuSystem offers pumps a …
  • Genfit SA (GNFT)-医療機器分野:企業M&A・提携分析
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s product pipeline comprise GFT505, TGFTX1, TGFTX3, TGFTX4, TGFTX5 and SAN/GFT-2. Its TGFTX1 can be …
  • BH Global Corporation Ltd (BQN):企業のM&A・提携動向(石油・ガス分野)
    Summary BH Global Corporation Ltd (BH Global), is an oil and gas service provider that offers supply chain management, design and manufacturing solutions, and engineering services. The company operates through its segments which includes supply chain management, design and manufacturing, and enginee …
  • Banco Pastor, S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Banco Pastor, S.A. Mergers and …
  • Phosplatin Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Phosplatin Therapeutics LLC (Phosplatin Therapeutics) is a drug development company that carries out the clinical development of phosphaplatins products. The company develops small-molecule compounds which are used for the treatment of cancer. It has collaborations with various contract rese …
  • Ignyta Inc (RXDX)-製薬・医療分野:企業M&A・提携分析
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc is a drug manufacturing company that discovers, develops and commercializes new drugs targeting activated genes in cancer cells for the treatment of cancer patients. The company develops products using integrated therapeutic (Rx) and companion diagnost …
  • Cardiac Dimensions Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cardiac Dimensions Inc (Cardiac Dimensions) is a medical equipment company that develops intervention tools used for treating heart failure and other related cardiovascular conditions. The company develops carillon mitral contour system, a coronary sinus-based percutaneous mitral annuloplast …
  • Bafna Pharmaceuticals Ltd (BAFNAPHARM):企業の財務・戦略的SWOT分析
    Summary Bafna Pharmaceuticals Ltd (Bafna Pharmaceuticals) is a pharmaceutical company that manufactures and markets medicinal products. The company provides operations such as domestic marketing, international marketing, international export and business development, among others. It offers products …
  • Intel Corporation:企業の戦略・SWOT・財務分析
    SummaryIntel Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆